146 related articles for article (PubMed ID: 11139453)
21. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
[TBL] [Abstract][Full Text] [Related]
22. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
[TBL] [Abstract][Full Text] [Related]
23. Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.
Douglas SA; Vickery-Clark LM; Louden C; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S186-9. PubMed ID: 8587358
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
Richard V; Hogie M; Thuillez C
Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
[TBL] [Abstract][Full Text] [Related]
25. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous knock-Out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse.
Berthiaume N; Yanagisawa M; Labonté J; D'Orléans-Juste P
Hypertension; 2000 Dec; 36(6):1002-7. PubMed ID: 11116115
[TBL] [Abstract][Full Text] [Related]
27. Effect of novel mixed ETA/ETB antagonists on responses to ET-1 in human small muscular pulmonary arteries.
MacLean MR; Docherty CC; McCulloch KM; Morecroft I
Pulm Pharmacol Ther; 1998; 11(2-3):147-9. PubMed ID: 9918747
[TBL] [Abstract][Full Text] [Related]
28. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
Hay DW; Luttmann MA; Beck G; Ohlstein EH
Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
[TBL] [Abstract][Full Text] [Related]
29. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
Hay DW; Luttmann MA
J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312
[TBL] [Abstract][Full Text] [Related]
30. Effects of endothelin in radiocontrast-induced nephropathy in rats are mediated through endothelin-A receptors.
Bird JE; Giancarli MR; Megill JR; Durham SK
J Am Soc Nephrol; 1996 Aug; 7(8):1153-7. PubMed ID: 8866406
[TBL] [Abstract][Full Text] [Related]
31. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension.
Douglas SA; Gellai M; Ezekiel M; Ohlstein EH
J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular responses mediated by two types of endothelin ET(B) receptor in spontaneously hypertensive and Wistar-Kyoto rats.
Kuwahara M; Masuda T; Tsubone H; Sugano S; Karaki H
Eur J Pharmacol; 1996 Jan; 296(1):55-63. PubMed ID: 8720477
[TBL] [Abstract][Full Text] [Related]
33. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
34. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
Gardiner SM; March JE; Kemp PA; Fallgren B; Bennett T
Br J Pharmacol; 2004 Feb; 141(4):634-43. PubMed ID: 14744807
[TBL] [Abstract][Full Text] [Related]
35. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Sep; 116(2):1718-9. PubMed ID: 8528549
[TBL] [Abstract][Full Text] [Related]
37. Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.
Ajayi AA; Ogungbade GO; Hercule HC; Oyekan AO; Mutembei L
Diabetes Res Clin Pract; 2004 Mar; 63(3):155-69. PubMed ID: 14757287
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-1-induced elevation in blood pressure is independent of increases in sympathetic nerve activity in normotensive rats.
Xu H; Fink GD; Galligan JJ
J Cardiovasc Pharmacol; 2001 Nov; 38(5):784-95. PubMed ID: 11602825
[TBL] [Abstract][Full Text] [Related]
39. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
Ruetten H; Thiemermann C; Vane JR
Br J Pharmacol; 1996 May; 118(1):198-204. PubMed ID: 8733596
[TBL] [Abstract][Full Text] [Related]
40. Depressor role of angiotensin AT2 receptors in the (mRen-2)27 transgenic rat.
Nishioka T; Morris M; Li P; Ganten D; Ferrario CM; Callahan MF
Am J Hypertens; 1998 Mar; 11(3 Pt 1):357-62. PubMed ID: 9544877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
